These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38458570)

  • 1. Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulation.
    Shang Y; Zhu Q; Ding J; Zhao L; Zhang F; Lu J; Feng Y; Wang J; Liu Z; Kuang M; Li C
    J Control Release; 2024 May; 369():75-87. PubMed ID: 38458570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels.
    Yang C; Mariner PD; Nahreini JN; Anseth KS
    J Control Release; 2012 Sep; 162(3):612-8. PubMed ID: 22902591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP-2 Derived Peptide and Dexamethasone Incorporated Mesoporous Silica Nanoparticles for Enhanced Osteogenic Differentiation of Bone Mesenchymal Stem Cells.
    Zhou X; Feng W; Qiu K; Chen L; Wang W; Nie W; Mo X; He C
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):15777-89. PubMed ID: 26133753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration on You-Gui Yin and low-dose Raloxifene partially attenuates the bone loss in ovariectomized mice through the proliferation and osteogenic differentiation of bone marrow stromal cells.
    Qi XY; Liu H; Bi DD; Wang XT; Guo YF; Hao T; Zhang BX; Wang XG; Han MH
    Phytomedicine; 2019 Feb; 53():286-293. PubMed ID: 30668409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
    Wang L; Zhang HY; Gao B; Shi J; Huang Q; Han YH; Hu YQ; Lu WG; Zhao ZJ; Liu BH; Jie Q; Yang L; Luo ZJ
    Stem Cells Dev; 2017 Mar; 26(6):419-430. PubMed ID: 27917698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of intertrochanteric bone quality in osteoporotic female rats after injection of polylactic acid-polyglycolic acid copolymer/collagen type I microspheres combined with bone mesenchymal stem cells.
    Yu Z; Zhu T; Li C; Shi X; Liu X; Yang X; Sun H
    Int Orthop; 2012 Oct; 36(10):2163-71. PubMed ID: 22539160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Teriparatide in Glucocorticoid-induced Osteoporosis through Regulating Cellular Reactive Oxygen Species.
    Wang T; Han C; Tian P; Li PF; Ma XL
    Orthop Surg; 2018 May; 10(2):152-159. PubMed ID: 29745033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-loaded β-cyclodextrin for osteogenic induction of mesenchymal stem/progenitor cells and bone regeneration.
    Li X; Xu L; Nie H; Lei L
    J Biomed Mater Res A; 2021 Jul; 109(7):1125-1135. PubMed ID: 32981208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
    Dalle Carbonare L; Arlot ME; Chavassieux PM; Roux JP; Portero NR; Meunier PJ
    J Bone Miner Res; 2001 Jan; 16(1):97-103. PubMed ID: 11149495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats.
    Böcker W; El Khassawna T; Bauer N; Brodsky K; Weisweiler D; Govindarajan P; Schlewitz G; Kampschulte M; Dürselen L; Thormann U; Szalay G; Schnettler R; Langheinrich AC; Heiss C
    Eur Spine J; 2014 Nov; 23(11):2437-48. PubMed ID: 25077942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
    Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
    Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone promotes the endoplasmic reticulum stress response of bone marrow mesenchymal stem cells by activating the PERK-Nrf2 signaling pathway.
    Cheng S; Liu X; Gong F; Ding X; Zhou X; Liu C; Zhao F; Li X; Shi J
    Pharmacol Res Perspect; 2021 May; 9(3):e00791. PubMed ID: 34038621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p.
    Kang H; Chen H; Huang P; Qi J; Qian N; Deng L; Guo L
    Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.
    Boehm M; Beaumont K; Jones R; Kalgutkar AS; Zhang L; Atkinson K; Bai G; Brown JA; Eng H; Goetz GH; Holder BR; Khunte B; Lazzaro S; Limberakis C; Ryu S; Shapiro MJ; Tylaska L; Yan J; Turner R; Leung SSF; Ramaseshan M; Price DA; Liras S; Jacobson MP; Earp DJ; Lokey RS; Mathiowetz AM; Menhaji-Klotz E
    J Med Chem; 2017 Dec; 60(23):9653-9663. PubMed ID: 29045152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation.
    Li J; Zhang N; Huang X; Xu J; Fernandes JC; Dai K; Zhang X
    Cell Death Dis; 2013 Oct; 4(10):e832. PubMed ID: 24091675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis.
    Xia T; Dong X; Lin L; Jiang Y; Ma X; Xin H; Zhang Q; Qin L
    J Pharm Biomed Anal; 2019 Mar; 166():336-346. PubMed ID: 30690247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalpol ameliorates dexamethasone-induced osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via the activation of PKD1 promoter.
    Xu L; Xu G; Sun N; Yao J; Wang C; Zhang W; Tian K; Liu M; Sun H
    J Pharmacol Sci; 2023 Dec; 153(4):221-231. PubMed ID: 37973220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density.
    Grahnemo L; Jochems C; Andersson A; Engdahl C; Ohlsson C; Islander U; Carlsten H
    J Endocrinol; 2015 Jan; 224(1):97-108. PubMed ID: 25359897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective osteogenesis by a synthetic mineral inducing peptide for the treatment of osteoporosis.
    Park YS; Lee JY; Suh JS; Jin YM; Yu Y; Kim HY; Park YJ; Chung CP; Jo I
    Biomaterials; 2014 Dec; 35(37):9747-9754. PubMed ID: 25205451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.